Epax

Activities: Ingredients

Part of Norwegian fishery giant Pelagia AS, Epax Norway AS is a leading manufacturer of concentrated marine oils.

Visit website

Profile

Epax has been an innovator for over 180 years. Since 1838, when it began producing premium quality cod liver oil, Epax has transformed the marine ingredients sector. It invented the technology to concentrate fish oil as an ethyl ester, and to re-esterify oils back to TG-form. It was also the first company to create condition-specific EPA/DHA ingredients backed by science.

Today Epax continues to deliver Omega-3 products of unmatched purity and quality. The Epax production facility in Ålesund, Norway has, in addition to all standard manufacturing certifications/approvals, been approved by the US FDA for manufacture of Pharmaceutical Intermediates and by the Norwegian Medicines Agency (Legemiddelverket) for the production of Active Pharmaceutical Ingredients (APIs).

Epax

Social media

Epax

Trending Articles

  1. dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on...
  2. Tate & Lyle debuts mouthfeel trend report for better food and beverage formulation The company highlights the top nine most popular trends in food and beverage formulation, including hyper-crunch, mouthfeel mimicry and climate-proof food
  3. Alland & Robert continues to lead the way with gum acacia solutions that contribute to a healthier and more sustainable future As the global leader and pioneer of natural gums, Alland & Robert is focused on creating ingredients for a healthier tomorrow and providing tailor-made support for innovation...
  4. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Study reveals astaxanthin's cardiovascular health-boosting potential in firefighters AstaReal's Astaxanthin nutraceutical has been shown to elevate biomarkers of heart health at a dose of 12mg per day, while also mediating inflammation associated with...

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

Related Content

Manufacturing

Epax slashes carbon emissions in its transition to renewables

The company is now powered by 100% renewable energy and has reduced its emissions by 22.3% in the last 4 years
Ingredients

Omega dream team: Epax launches first concentrated oil to combine LC-MUFAs and LC-PUFAs

Epax has launched a full-spectrum oil offering a unique combination of Omegas 3, 9 and 11, with particular potential for skin health supplements
Ingredients

Epax reports "close to total circularity" for marine biomaterials

The achievement was announced in the Norwegian marine lipid specialist’s first annual Environment, Social and Governance (ESG) Report
Manufacturing

Distillation technology creates opportunities for ultra-concentrated Omega-3

The black box-protected technology is the result of years of research and development
Ingredients

Epax launches marine lipid innovator

It will be showcased in the New Products Zone at SupplySide West 2022 at Booth #3831
Research & Development

Epax granted $900k for Omega-3 research

Last year, the company announced it was investing $35m to expand capacity, allowing output at its main production facility in Ålesund to increase by more than 50% by 2021
Ingredients

Food for thought: how diet and supplementation can help fight dementia

Dr Morten Bryhn, Scientific Adviser at marine oil innovator, Epax, explains the potential of early intervention with omega-3 and carotenoids to help prevent the development of Alzheimer’s disease
Subscribe now